skip to main content
Global Search Configuration

Download Your Copy Now

Don't miss out on this comprehensive review of all the presentations from the conference, complied by our analysts, with key points and expert insight, for you to download, for free. A full list of events and catalysts that were announced or updated during the conference is included in this report.

Below are some of the key points from the conference’s presentations which are covered in detail in the full report:

  • Celgene (CELG) announced acquiring Impact Biomedicines and its late-stage myelofibrosis asset fedratinib
  • Regeneron Pharmaceuticals (REGN) announced the biggest news with an additional $1bn commitment from Regeneron and Sanofi towards cemiplimab
  • Pfizer highlighted H1 2018 milestones
  • Roche Holding’s (RHHBY) highlighted the company’s sixth consecutive year of sales growth
  • AbbVie (ABBV) focused on its flagship product, Humira
  • Spark Therapeutics (ONCE) announced a new gene therapy program
JP Morgan Healthcare Review 2018

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: